Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression

Bron
Cell death and differentiation - ISSN 1350-9047-30:9 (2023) p. 2092-2103
Auteur(s)

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

Bron
Nature communications - ISSN 2041-1723-13:1 (2022) p.
Auteur(s)

Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL

Bron
Cell Death and Disease - ISSN 2041-4889-12:5 (2021) p.
Auteur(s)